BG
VXRT

BlackRock Group’s Vaxart VXRT Stock Holding History

BlackRock Group’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14,400
Closed -$391K – 2914
2014
Q3 		$391K Hold
14,400
– – ﹤0.01% 2267
2014
Q2 		$451K Hold
14,400
– – ﹤0.01% 2240
2014
Q1 		$968K Hold
14,400
– – ﹤0.01% 1997
2013
Q4 		$664K Hold
14,400
– – ﹤0.01% 2136
2013
Q3 		$662K Buy
+14,400
New +$624K ﹤0.01% 2113

Other funds holding VXRT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Group's VXRT Position: Q4 2014 in Review

BlackRock Group sold out of Vaxart (VXRT) in Q4 2014, closing a stake of 14,400 shares — an estimated $391K sold.

BlackRock Group first reported a position in VXRT in Q3 2013 and held it in 5 quarters. The position peaked at $968K in Q1 2014. 46 funds tracked by Wall St. Rank hold VXRT as of Q4 2014.

  • BlackRock Group reported no remaining Vaxart position as of Q4 2014 after selling out during the quarter.
  • BlackRock Group sold 14,400 Vaxart shares in Q4 2014, an estimated $391K.
  • BlackRock Group first reported a position in Vaxart in Q3 2013 and held it in 5 quarters.
  • BlackRock Group's Vaxart position peaked at $968K in Q1 2014.
  • 46 funds tracked by Wall St. Rank held Vaxart as of Q4 2014.

Based on BlackRock Group's 13F filing for Q4 2014, filed 9 Feb 2015.